Shaopeng Yuan

Shaopeng Yuan

Auto-generated profile, based on publicly available information

Shaopeng Yuan

Howard Hughes Medical Institute, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, New York, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Cell
Verified
Journal Article
Closed access
NANicholas Arpaia
Nicholas Arpaia
JGJesse A. Green
Jesse A. Green
BMBruno Moltedo
Bruno Moltedo
AAAaron Arvey
Aaron Arvey
SHSaskia Hemmers
Saskia Hemmers
ARAlexander Y. Rudensky
Alexander Y. Rudensky

18 October 2017 in Nature
Verified
Journal Article
Open access
PDF file
SNShruti Naik
Shruti Naik
SLSamantha B. Larsen
Samantha B. Larsen
NGNicholas C. Gomez
Nicholas C. Gomez
KAKirill Alaverdyan
Kirill Alaverdyan
ASAtaman Sendoel
Ataman Sendoel
EFElaine Fuchs
Elaine Fuchs
The skin barrier is the body’s first line of defence against environmental assaults, and is maintained by epithelial stem cells (EpSCs). Despite the vulnerability of EpSCs to inflammatory pressures, neither the primary response to inflammation nor its enduring consequences are well understood. Here we report a prolonged memory to acute inflammation that enables mouse EpSCs to hasten barrier restoration after subsequent tissue damage. This functional adaptation does not require skin-resident macrophages or T cells. Instead, EpSCs maintain chromosomal accessibility at key stress response genes that are activated by the primary stimulus. Upon a secondary challenge, genes governed by these domains are transcribed rapidly. Fuelling this memory is Aim2, which encodes an activator of the inflammasome. The absence of AIM2 or its downstream effectors, caspase-1 and interleukin-1β, erases the ability of EpSCs to recollect inflammation. Although EpSCs benefit from inflammatory tuning by heightening their responsiveness to subsequent stressors, this enhanced sensitivity probably increases their susceptibility to autoimmune and hyperproliferative disorders, including cancer.

26 July 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SSSukhvinder S Sidhu
Sukhvinder S Sidhu
SYShaopeng Yuan
Shaopeng Yuan
AIAnh L. Innes
Anh L. Innes
SKSheena Kerr
Sheena Kerr
PWPrescott G. Woodruff
Prescott G. Woodruff
JFJohn V. Fahy
John V. Fahy
Periostin is considered to be a matricellular protein with expression typically confined to cells of mesenchymal origin. Here, by using in situ hybridization, we show that periostin is specifically up-regulated in bronchial epithelial cells of asthmatic subjects, and in vitro, we show that periostin protein is basally secreted by airway epithelial cells in response to IL-13 to influence epithelial cell function, epithelial–mesenchymal interactions, and extracellular matrix organization. In primary human bronchial epithelial cells stimulated with periostin and epithelial cells overexpressing periostin, we reveal a function for periostin in stimulating the TGF-β signaling pathway in a mechanism involving matrix metalloproteinases 2 and 9. Furthermore, conditioned medium from the epithelial cells overexpressing periostin caused TGF-β–dependent secretion of type 1 collagen by airway fibroblasts. In addition, mixing recombinant periostin with type 1 collagen in solution caused a dramatic increase in the elastic modulus of the collagen gel, indicating that periostin alters collagen fibrillogenesis or cross-linking and leads to stiffening of the matrix. Epithelial cell-derived periostin in asthma has roles in TGF-β activation and collagen gel elasticity in asthma.

1 May 2017 in Cell
Verified
Journal Article
Closed access
YGYejing Ge
Yejing Ge
NGNicholas C. Gomez
Nicholas C. Gomez
RARene C. Adam
Rene C. Adam
MNMaria Nikolova
Maria Nikolova
HYHanseul Yang
Hanseul Yang
EFElaine Fuchs
Elaine Fuchs

1 February 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MPMichael C. Peters
Michael C. Peters
ZMZesemayat K. Mekonnen
Zesemayat K. Mekonnen
SYShaopeng Yuan
Shaopeng Yuan
NBNirav R. Bhakta
Nirav R. Bhakta
PWPrescott G. Woodruff
Prescott G. Woodruff
JFJohn V. Fahy
John V. Fahy

25 February 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SYShaopeng Yuan
Shaopeng Yuan
MHMartin Hollinger
Martin Hollinger
MLMarrah Elizabeth Lachowicz-Scroggins
Marrah Elizabeth Lachowicz-Scroggins
SKSheena C. Kerr
Sheena C. Kerr
EDEleanor M. Dunican
Eleanor M. Dunican
JFJohn V. Fahy
John V. Fahy
Airway mucus in cystic fibrosis (CF) is highly elastic, but the mechanism behind this pathology is unclear. We hypothesized that the biophysical properties of CF mucus are altered because of neutrophilic oxidative stress. Using confocal imaging, rheology, and biochemical measures of inflammation and oxidation, we found that CF airway mucus gels have a molecular architecture characterized by a core of mucin covered by a web of DNA and a rheological profile characterized by high elasticity that can be normalized by chemical reduction. We also found that high levels of reactive oxygen species in CF mucus correlated positively and significantly with high concentrations of the oxidized products of cysteine (disulfide cross-links). To directly determine whether oxidation can cross-link mucins to increase mucus elasticity, we exposed induced sputum from healthy subjects to oxidizing stimuli and found a marked and thiol-dependent increase in sputum elasticity. Targeting mucin disulfide cross-links using current thiol-amino structures such as N-acetylcysteine (NAC) requires high drug concentrations to have mucolytic effects. We therefore synthesized a thiol-carbohydrate structure (methyl 6-thio-6-deoxy-α-d-galactopyranoside) and found that it had stronger reducing activity than NAC and more potent and fast-acting mucolytic activity in CF sputum. Thus, oxidation arising from airway inflammation or environmental exposure contributes to pathologic mucus gel formation in the lung, which suggests that it can be targeted by thiol-modified carbohydrates.